1. Home
  2. ASMB vs FC Comparison

ASMB vs FC Comparison

Compare ASMB & FC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • FC
  • Stock Information
  • Founded
  • ASMB 2005
  • FC 1983
  • Country
  • ASMB United States
  • FC United States
  • Employees
  • ASMB N/A
  • FC N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • FC Other Consumer Services
  • Sector
  • ASMB Health Care
  • FC Consumer Discretionary
  • Exchange
  • ASMB Nasdaq
  • FC Nasdaq
  • Market Cap
  • ASMB 225.9M
  • FC 236.1M
  • IPO Year
  • ASMB 2010
  • FC 1992
  • Fundamental
  • Price
  • ASMB $31.43
  • FC $16.47
  • Analyst Decision
  • ASMB Strong Buy
  • FC Strong Buy
  • Analyst Count
  • ASMB 5
  • FC 2
  • Target Price
  • ASMB $44.25
  • FC $27.00
  • AVG Volume (30 Days)
  • ASMB 141.0K
  • FC 95.2K
  • Earning Date
  • ASMB 11-07-2025
  • FC 11-05-2025
  • Dividend Yield
  • ASMB N/A
  • FC N/A
  • EPS Growth
  • ASMB N/A
  • FC N/A
  • EPS
  • ASMB N/A
  • FC 0.81
  • Revenue
  • ASMB $33,247,000.00
  • FC $279,943,000.00
  • Revenue This Year
  • ASMB $14.29
  • FC N/A
  • Revenue Next Year
  • ASMB N/A
  • FC $1.23
  • P/E Ratio
  • ASMB N/A
  • FC $21.75
  • Revenue Growth
  • ASMB 54.77
  • FC N/A
  • 52 Week Low
  • ASMB $7.75
  • FC $16.29
  • 52 Week High
  • ASMB $32.44
  • FC $44.16
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 63.80
  • FC 39.42
  • Support Level
  • ASMB $30.00
  • FC $16.29
  • Resistance Level
  • ASMB $31.80
  • FC $17.86
  • Average True Range (ATR)
  • ASMB 1.64
  • FC 0.90
  • MACD
  • ASMB 0.07
  • FC -0.08
  • Stochastic Oscillator
  • ASMB 77.72
  • FC 10.72

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About FC Franklin Covey Company

Franklin Covey Co is a company focused on organizational performance improvement. It focuses on providing time management and effectiveness training for individuals and corporations via online training as well as in-person workshops and events. The company provides training and consulting services in the areas of leadership, execution, productivity, trust, sales performance, customer loyalty, and educational improvement. It operates in the business segments of Direct Offices, Education division, and International Licensees. The company derives revenue from providing training and consulting services, and through the selling of books, audio media, and other related products. It has a business presence in the Australia, New Zealand, China, Japan, United Kingdom, Ireland, and Other countries.

Share on Social Networks: